Atai Life Sciences at Life

Atai Life Sciences. With tentacles in berlin, new york and amsterdam, atai has raised large amounts of backing to finance research into psychedelic medicines for depression and other mental illnesses. Atai is dedicated to acquiring, incubating, and efficiently developing.

49 number of organizations • $376.7m total funding amount • 40 number of investors. Headquartered in berlin, with offices in new york and london, our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life. Atai is dedicated to acquiring, incubating, and efficiently developing.

Biopharmaceutical Company ATAI Life Sciences Pops on

With tentacles in berlin, new york and amsterdam, atai has raised large amounts of backing to finance research into psychedelic medicines for depression and other mental illnesses. Investors active in saint laurent, quebec. Atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. Atai life sciences was founded in 2018 and is based in munich, bayern, germany.